Full-Time

Fleet and Transport Manager

Posted on 9/8/2025

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Birmingham, UK

In Person

Some UK travel required, with overnight stays and attendance at meetings or conventions outside of normal business hours.

Category
Operations & Logistics (2)
,
Required Skills
Word/Pages/Docs
Customer Service
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Experience of managing teams including at remote locations
  • Working in a highly regulated / audited working environment
  • Operating on own initiative as the site Fleet and Transport Manager
  • Leading the Health and Safety agenda for transport
  • Experience of temperature-controlled distribution
  • Strong understanding of transport operations, including compliance with legal standards such as tachograph rules, vehicle maintenance, and driver hours.
  • Knowledge of Health and Safety regulations and best practices within a transport environment.
  • Familiarity with fleet management systems and KPI reporting.
  • Ability to embrace and implement change to improve business performance.
  • Strong organisational skills to manage time, tasks, and resources effectively, ensuring deadlines and targets are met.
  • Analytical skills to identify issues, interpret data, and implement practical solutions.
  • Awareness of customer service principles and the importance of maintaining high delivery standards.
  • Understanding of temperature-controlled distribution requirements and standards.
  • Proficient in Microsoft tools including 365, Excel, PowerPoint, Word and Teams
  • CPC holder: A Certificate of Professional Competence (CPC) is essential for this role.
  • Proven experience in a fleet or transport management role, with a track record of maintaining compliance and operational efficiency.
  • Experience managing a mixed fleet of LGVs and LCVs, including vehicles based at remote locations.
  • Experience working in a highly regulated and audited environment, ensuring compliance with all standards.
  • Clear, engaging and effective communication skills to engage with team members, customers, and stakeholders - well informed on all important matters that are relevant to the role.
  • Demonstrated success in leading teams and driving employee engagement and development.
  • Experience in investigating and resolving customer service issues.
  • Familiarity with conducting audits and implementing action plans to address identified issues.
  • Having the composure and ability to adapt to stressful situations and deal with emergencies or last-minute changes to schedules.
Responsibilities
  • Take responsibility for all areas of people management for direct reports, including coaching, nurturing talent, and motivating the team through effective leadership.
  • Manage driver rotas to ensure trained cover for absences, maintaining operational continuity.
  • Provide coaching and guidance to team members, fostering a culture of continuous improvement and professional development.
  • Manage teams, including those at remote locations, ensuring consistent communication and operational alignment.
  • Conduct performance reviews and provide timely feedback to all team members.
  • Foster an inclusive and supportive team environment by promoting diversity, respecting individual differences, and ensuring all team members feel valued and empowered to contribute to the success of Cencora Alliance Healthcare.
  • Ensure transport operational costs remain within budget by implementing and monitoring robust control mechanisms.
  • Analyse cost performance and address any variances through corrective actions to maintain financial efficiency.
  • Build a robust working relationship with the appointed transport finance lead.
  • Ensure drivers comply with hours, tachograph rules, and speed limits, adhering to all legal requirements.
  • Maintain all vehicles to company and legislative standards, ensuring safety and reliability.
  • Ensure vehicles are not overloaded and only authorised vehicles are kept at the designated Operating Centre(s) when not in use.
  • Ensure all documentation is completed accurately and in line with statutory requirements.
  • Oversee the compilation and accuracy of all service and maintenance records to ensure compliance with legal and company standards.
  • Complete monthly Fleet Key Performance Indicators (KPIs) by agreed deadlines, monitor performance, and address issues through remedial action plans.
  • Participate in internal fleet audits, ensuring any identified issues are resolved through the execution of action plans.
  • Manage and oversee temperature-controlled distribution operations, ensuring compliance with regulatory and operational standards.
  • Ensure all vehicles and processes meet the specific requirements for temperature-sensitive goods.
  • Manage a mixed fleet of LGVs and LCVs, including vehicles based at remote locations, ensuring they meet operational and compliance requirements.
  • Ensure all customer deliveries are completed in the prescribed manner, meeting agreed service standards.
  • Investigate customer service issues promptly, provide feedback, and implement remedial actions to prevent recurrence.
  • Maintain a customer-focused approach, ensuring customer needs are prioritised and productive relationships are built and sustained.
  • Lead the Health and Safety agenda for transport, ensuring the department meets all Health and Safety (H&S) requirements.
  • Conduct regular reviews, training, and risk assessments to mitigate potential hazards.
  • Ensure team members are fully aware of their H&S responsibilities and promote a culture of safety across the transport operation.
  • Make recommendations for improvements in processes and procedures within the area of responsibility.
  • Implement corporate processes and procedures in a consistent manner, ensuring alignment with organisational standards.
  • Work with management team members to develop a culture of continuous improvement across the Service Centre and satellite sites.
  • Actively seek opportunities to enhance operational efficiency and make recommendations for improvement.
  • Operate on own initiative as the site Fleet and Transport Manager, making informed decisions to ensure operational success.
  • Take ownership of transport-related challenges, resolving issues promptly and effectively.
Desired Qualifications
  • Familiarity with conducting audits and implementing action plans to address identified issues.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.

INACTIVE